Yuh-Min Chen
Overview
Explore the profile of Yuh-Min Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
243
Citations
4816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang T, Wang C, Hong J, Chao H, Chen Y, Wu Y
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002216
Detecting lung nodules on computed tomography (CT) images is critical for diagnosing thoracic cancers. Deep learning models, particularly convolutional neural networks (CNNs), show promise in automating this process. This systematic...
2.
Lin F, Cheng H, Yih M, Huang S, Su K, Chou K, et al.
Hypertens Res
. 2025 Jan;
PMID: 39871002
To explore the effects of obstructive sleep apnea (OSA) on nocturnal changes in blood pressure (BP), we enrolled 2037 participants who underwent polysomnography (PSG) between 2019 and 2020 and examined...
3.
Tseng Y, Tran T, Chang J, Huang Y, Nguyen A, Yi-Feng Chang I, et al.
Cell Death Discov
. 2025 Jan;
11(1):26.
PMID: 39870629
TP53 mutations are recognized to correlate with a worse prognosis in individuals with non-small cell lung cancer (NSCLC). There exists an immediate necessity to pinpoint selective treatment for patients carrying...
4.
Sun R, Liao P, Liao Y, Yeh Y, Chiang C, Chen Y, et al.
J Chin Med Assoc
. 2025 Jan;
PMID: 39865515
Background: Limited information is available regarding the clinical features and outcomes of advanced human epidermal growth factor receptor 2 (HER2)-mutant non-small cell lung cancer (NSCLC) in Taiwan, despite expanding treatment...
5.
Banerjee O, Saenz A, Wu K, Clements W, Zia A, Buensalido D, et al.
Pac Symp Biocomput
. 2024 Dec;
30:185-198.
PMID: 39670370
Given the rapidly expanding capabilities of generative AI models for radiology, there is a need for robust metrics that can accurately measure the quality of AI-generated radiology reports across diverse...
6.
Blechter B, Hsiung C, Wang X, Zhang H, Seow W, Shi J, et al.
J Thorac Oncol
. 2024 Nov;
PMID: 39581378
We assessed the association between a genome-wide polygenic risk score (PRS) developed for lung adenocarcinoma (LUAD) risk and mutation on the EGFR gene in 998 East Asian never-smoking female LUAD...
7.
Chang C, Huang J, Shen H, Sun C, Liao Y, Ko H, et al.
J Formos Med Assoc
. 2024 Nov;
PMID: 39488498
Background: Comparing the outcomes of intensive care unit (ICU) admitted COVID-19 patients during the Alpha and Omicron-dominated periods. Methods: Patients with critical COVID-19 disease, requiring ICU admission from May to...
8.
Chang C, Huang J, Tseng Y, Pan S, Feng J, Su W, et al.
Diagn Microbiol Infect Dis
. 2024 Oct;
111(1):116559.
PMID: 39476771
Introduction: To investigate whether the methylation of circulating cell-free DNA (cfDNA) differentiates active tuberculosis (TB) from latent TB infection (LTBI). Methods: Patients with pulmonary TB, contacts with LTBI, and healthy...
9.
Luo Y, Shen C, Chiang C, Chen Y
Ther Adv Med Oncol
. 2024 Oct;
16:17588359241284946.
PMID: 39391353
Background: Programmed cell death protein 1 ligand 1 (PD-L1) expression alone may not be the optimal predictor of immunotherapy (IO) efficacy in advanced non-small cell lung cancer (NSCLC). Evaluation of...
10.
Liao C, Chen Y, Wu Y, Chao H, Chiu H, Wang T, et al.
Cancer Imaging
. 2024 Oct;
24(1):129.
PMID: 39350284
Background: Lung cancer (LC) is a leading cause of cancer-related mortality, and immunotherapy (IO) has shown promise in treating advanced-stage LC. However, identifying patients likely to benefit from IO and...